Palo Alto Investors LP Long-Term Concentrated

Location: Palo Alto, CA

CIK: 0001306923 · Show all filings

Period: Q2 2024 (← Previous) (Next →)

Filing Date: Aug 14, 2024

Total Value: $863M (100.0% shares, 0.0% debt)

Holdings (39)

INSM INSMED INC 16.6%
Value $143M Shares 2,138,963 Est. Cost $17.79 Unrealized +118.0%
BMRN BIOMARIN PHARMACEUTICAL INC 10.8%
Value $93.05M Shares 1,130,167 Est. Cost $83.16 Unrealized +0.1%
FOLD AMICUS THERAPEUTICS INC 10.4%
Value $89.58M Shares 9,029,843 Est. Cost $9.63 Unrealized +6.6%
UTHR UNITED THERAPEUTICS CORP 9.9%
Value $85.03M Shares 266,914 Est. Cost $89.23 Unrealized +196.6%
BIIB BIOGEN INC 7.8%
Value $67.01M Shares 289,050 Est. Cost $264.98 Unrealized -18.0%
STAA STAAR SURGICAL CO 7.6%
Value $65.78M Shares 1,381,619 Est. Cost $24.23 Unrealized +80.8%
ALNYLAM PHARMACEUTICALS INC 5.2%
Value $44.5M Shares 183,123 Est. Cost $243.00 Unrealized
ACAD ACADIA PHARMACEUTICALS INC 4.6%
Value $39.31M Shares 2,418,841 Est. Cost $28.41 Unrealized -43.2%
PRTA PROTHENA CORP PLC 4.0%
Value $34.39M Shares 1,666,378 Est. Cost $21.46 Unrealized +0.9%
SRPT SAREPTA THERAPEUTICS INC 3.7%
Value $31.87M Shares 201,683 Est. Cost $111.32 Unrealized +15.4%
ANAB ANAPTYSBIO INC 2.3%
Value $20.14M Shares 803,641 Est. Cost $19.13 Unrealized +21.7%
IOVA IOVANCE BIOTHERAPEUTICS INC 2.0%
Value $16.97M Shares 2,116,403 Est. Cost $5.23 Unrealized +104.8%
REVANCE THERAPEUTICS INC 1.6%
Value $13.51M Shares 5,257,086 Est. Cost $21.40 Unrealized
ALKS ALKERMES PLC 1.4%
Value $11.94M Shares 495,592 Est. Cost $22.36 Unrealized +9.7%
SAGE THERAPEUTICS INC 1.3%
Value $10.98M Shares 1,010,833 Est. Cost $42.50 Unrealized
EHTH EHEALTH INC 1.2%
Value $10.65M Shares 2,350,190 Est. Cost $38.13 Unrealized -86.8%
NVCR NOVOCURE LTD 1.1%
Value $9.625M Shares 561,908 Est. Cost $58.84 Unrealized -70.1%
ALGN ALIGN TECHNOLOGY INC 1.1%
Value $9.119M Shares 37,772 Est. Cost $149.18 Unrealized +86.6%
SNDX SYNDAX PHARMACEUTICALS INC 1.0%
Value $8.319M Shares 405,193 Est. Cost $16.84 Unrealized +24.3%
ACELYRIN INC 0.9%
Value $7.564M Shares 1,715,180 Est. Cost $6.75 Unrealized
NEVRO CORP 0.7%
Value $6.318M Shares 750,371 Est. Cost $21.87 Unrealized
CYTK CYTOKINETICS INC 0.7%
Value $6.053M Shares 111,717 Est. Cost $6.71 Unrealized +799.1%
GOSS GOSSAMER BIO INC 0.7%
Value $5.655M Shares 6,277,093 Est. Cost $1.58 Unrealized -52.6%
ELEVATION ONCOLOGY INC 0.6%
Value $4.86M Shares 1,800,106 Est. Cost $4.52 Unrealized
BLUEBIRD BIO INC 0.5%
Value $4.56M Shares 4,633,351 Est. Cost $1.35 Unrealized
KARYOPHARM THERAPEUTICS INC 0.5%
Value $4.427M Shares 5,102,193 Est. Cost $16.36 Unrealized
VERVE THERAPEUTICS INC 0.3%
Value $2.81M Shares 575,817 Est. Cost $13.94 Unrealized
NUVB NUVATION BIO INC 0.3%
Value $2.256M Shares 772,652 Est. Cost $1.92 Unrealized +58.9%
MIRM MIRUM PHARMACEUTICALS INC 0.3%
Value $2.212M Shares 64,700 Est. Cost $15.56 Unrealized +68.5%
RLMD RELMADA THERAPEUTICS INC 0.3%
Value $2.197M Shares 732,400 Est. Cost $3.27 Unrealized +10.6%
TSHA TAYSHA GENE THERAPIES INC 0.2%
Value $1.817M Shares 811,268 Est. Cost $2.02 Unrealized +43.7%
STOK STOKE THERAPEUTICS INC 0.2%
Value $1.7M Shares 125,861 Est. Cost $6.06 Unrealized +122.9%
HUM HUMANA INC 0.2%
Value $1.489M Shares 3,985 Est. Cost $369.63 Unrealized -10.7%
TVTX TRAVERE THERAPEUTICS INC 0.1%
Value $910K Shares 110,719 Est. Cost $23.56 Unrealized -71.4%
VYNE VYNE THERAPEUTICS INC PIPE 0.1%
Value $878K Shares 445,434 Est. Cost $3.12 Unrealized -20.0%
ALDX ALDEYRA THERAPEUTICS INC 0.1%
Value $746K Shares 225,465 Est. Cost $5.95 Unrealized -34.1%
ACRS ACLARIS THERAPEUTICS INC 0.1%
Value $627K Shares 569,832 Est. Cost $1.19 Unrealized -1.5%
GENERATION BIO CO 0.0%
Value $424K Shares 150,475 Est. Cost $2.82 Unrealized
URGN UROGEN PHARMA LTD 0.0%
Value $411K Shares 24,500 Est. Cost $27.01 Unrealized -47.3%